Obesity and hypertension - The issue is more complex than we thought

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 264-267

  Narkiewicz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cardiovascular disease; Chronic kidney disease; Hypertension; Obesity

Indexed keywords

ATHEROSCLEROSIS; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; METABOLIC DISORDER; METABOLIC SYNDROME X; NEPHROSCLEROSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; WEIGHT REDUCTION;

HUMANS; HYPERTENSION; KIDNEY DISEASES; OBESITY;

EID: 31544479521     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi290     Document Type: Editorial

References (31)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217-223
2. Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-1209
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. J Am Med Assoc 2004; 291: 1238-1245
4. Krause RM, Winston M, Fletcher BJ, Grundy SM. Obesity. Impact on cardiovascular disease. Circulation 1998; 98: 1472-1476
5. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. PREVEND study group. Obesity and target organ damage: The kidney. Int J Obes Relat Metab Disord 2002; 26 [Suppl 4]: S21-S24
6. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001; 59: 1498-1509
7. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610-615
8. Praga M, Hernandez E, Herrero JC et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000; 58: 2111-2118
9. Bonnet F, Deprele C, Sassolas A et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001; 37: 720-727
10. Bosma RJ, Homan van der Heide JJ, Oosterop EJ, De Jong PE, Navis GJ. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004; 65: 259-265
11. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: The hypertension detection and follow-up program. Am J Kidney Dis 2005; 46: 587-594
12. Esiki K, Ikemiya Y, Kinjo K, Inoue T, Esiki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
13. Olshansky SJ, Passaro DJ, Hershow RC et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352: 1138-1145
14. Cassidy AE, Bielak LF, Zhou Y et al. Progression of subclinial coronary atherosclerosis. Does obesity make a difference? Circulation 2005; 111: 1877-1882
15. Engeli S, Sharma AM. Role of adipose tissue for cardiovascular-renal regulation in health and disease. Horm Metab Res 2000; 32: 485-499
16. Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue - a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002; 17: 191-195
17. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10: 3621-3637
18. Verdecchia P, Reboldi G, Angeli F et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 2004; 43: 963-969
19. Tylicki L, Rutkowski B. Metabolic disturbances as strong determinator of kidney injury in essential hypertension. J Hypertens 2005; 23: 1433-1434
20. Kincaid-Smith P. Hypothesis: Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'. J Hypertens 2004; 22: 1051-1055
21. Thomas F, Bean K, Pannier B, Oppert JM, Guize L, Benetos A. Cardiovascular mortality in overweight subjects: The key role of associated risk factors. Hypertension 2005; 46: 654-659
22. Julius S, Valentini M, Palatini P. Overweight and hypertension: A 2-way street? Hypertension 2000; 35: 807-813
23. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108
24. Engeli S, Bohnke J, Gorzelniak K et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356-362
25. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-809
26. Grassi G, Seravalle G, Colombo M et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97: 2037-2042
27. Nangaku M, Izuhara Y, Usuda N et al. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant 2005; 20: 2661-2669
28. Longenecker JC, Coresh J, Powe NR et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study. J Am Soc Nephrol 2002; 13: 1918-1927
29. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543-554
30. Kopple JD. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr 2005; 81: 1257-1266
31. McDonald S, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 2003; 14: 2484-2901